GeneNews Limited, a Toronto-based company focused on molecular diagnostic tests, signed up GeneDiagnostics Inc. as its non-exclusive China marketing partner for ColonSentry™, a blood-based test that determines a person's current risk for colorectal cancer. ColonSentry, the company’s first marketed product, is available in parts of Canada. More details...